Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07743242 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Autoimmune Hemolytic Anemia and Its Clinical Implication on Antiphospholipid Syndrome

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
AIHA is a heterogeneous autoimmune cytopenia with variable severity and significant morbidity. APS is defined by thrombosis and/or obstetric morbidity with persistent antiphospholipid antibodies (aPL).
Trial Details
NCT Number NCT07743242
Lead Sponsor New Valley University
Conditions
(from sponsor)		 Anti Phospholipid Syndrome
Related terms Antiphospholipid Syndrome
Enrollment 230 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov